Get complete information related to latest Scientific Journal Tenders . from India at Classic Tenders. Search the best available tenders from Indian government tenders, domestic Scientific Journal Tenders , private tenders, online tenders, tender invitation notice, business tender notices, online tenders and bidding Scientific Journal Tenders.
Tender For providing of paper-based printing services - as per sow; brochure; as per sow,paper-based printing services - as per sow; brochure; as per sow,paper-based printing services - as per sow; invitation cards; as per sow,paper-based printing services - as per sow; invitation cards; as per sow
Tender For supply of waterproof tentage , changing room for shooters , portable washroom , hd flex banners large with stand , hd flex banners large with stand 12ft x 6ft , hd flex banners large with stand 8ft x 1.5 ft , hd flex banners large with stand 12ft x 8ft , hd flex banners large with stand 6ft x 8ft , hd flex banners large with stand 20ft x 3ft , standees of size 8ft x 4ft with stand , event brochure, pamphlets , id cards with retainer , lounge facility with chairs and tables , chairs with cover , tables with clothes and frill , dustbins , water points with disposable glasses , projectors with screen, amplified sound system and 65 inch tv , various name tallies , air coolers , gifts or souvenirs , mementos , stage for prize distribution ceremony , pedestal fan , accreditation system
Tender For srphc82281240-coronary drug eluting stents with (1) stent on cobalt chromium alloy or platinum chromium alloy. (2) stent with coating of polymer carrier for active drug ( sirolimus everolimus or zotarolimus shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter should be from 2.5mm to 4mm and length of the stent should be 12mm to 48mm. (4) the strut thickness should be 91 micron or less. (5) stent delivery system should be monorail (single operator exchange or rapidexchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved by dcgi. the copy of dcgi approval should be enclosed in the tender bid. (9) the long term efficacy and safety of the stent in terms of target vessel revascularisation (tvr) and in-situ thrombosis (ist) should be documented / published in peer reviewed scientificjournals. (10) the documents related to the efficacy and safety of the stent should be only for the brand that is offered in the tender bid (11) the manufacturer/supplier should submit proof of supply of thestent to a major government institute. unit:no [ warranty period: 30 months after the date of delivery ] ]
Tender For supply of drug eluting stent -sirolimous drug with biodegrable polymer on cobalt chromium platform with active coating. size ranging from length 08 mm to 48 mm and width 2.25 mm to 5.0 mm. the quoted stent to be at least dcgi approved and three years efficacy and safety of the stent in terms of target vessel revascularisation (tvr) and in-situ thrombosis (ist) should be documented/published in peer reviewed scientificjournals. the documents pertaining to the efficacy and safety of the stent should be enclosed for the brand that is offered in the tender bid. replacement warranty against any manufacturing defect noted onthe o.t. table. the original company brochure mentioning the range of sizes (diameter & length) should besubmitted along with tender. [ai(2026-27), item code-no: s-62066, sl no.2010] ]
Tender For corrigendum : supply of material for office of the dy. director (buffer), tatr chandrapur - supply of material for office of the dy. director (buffer), tatr chandrapur, brochure tadoba dairies - 60 pages (130 gsm on glossy art paper), pamphlet butterflies of tatr (front & back with creasing) 250 gsm on bio-degradable paper, pamphlet birds of tatr (front & back with creasing) 250 gsm on bio-degradable paper
Tender For srphc82281240-coronary drug eluting stents with (1) stent on cobalt chromium alloy or platinum chromium alloy. (2) stent with coating of polymer carrier for active drug ( sirolimus, everolimus or zotarolimus shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter should be from 2.5mm to 4mm and length of the stent should be 12mm to 48mm. (4) the strut thickness should be 91 micron or less. (5) stent delivery system should be monorail (single operator exchange or rapid exchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved by dcgi. the copy of dcgi approval shouldbe enclosed in the tender bid. (9) the long term efficacy and safety of the stent in terms of target vessel revascularisation (tvr) and in-situ thrombosis (ist) should be documented / published in peer reviewed scientificjournals. (10) the documents related to the efficacy and safety of the stent should be only for the brand that is offered in the tender bid (11) the manufacturer/supplier should submit proof of supply of the stent toa major government institute.[quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]
Tender For srphc82281215-coronary drug eluting stents (1) with single wire design with cobalt alloy shell and platinum iridium core (2) stent with coating of biolinx polymer carrier for active drug zotarolimus shown to be effective in preventing neo-intimal hyperplasia (3) stent diameter should be from 2 mm to 5mm and length of the stent from 8 mm to 38 mm. (4) the strut should be round with thickness ranging from 81 to 91 microns (5) stent delivery system should be monorail (single operator exchange or rapidexchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved by dcgi. the copy of dcgi approval should be enclosed in the tender bid. (9) five years efficacy and safety of the stent in terms of target vessel revascularisation (tvr) and in-situ thrombosis (ist) should be documented / published in peer reviewed scientificjournals.(10) the documents pertaining to the efficacy and safety of the stent should be enclosed for the brand that is offered in the tender bid (11) the manufacturer/supplier should submit proof of supply of the stent to a major government institute. ]
Tender For supply of urine bag has a capacity of 2 litres and is graduated every 100 ml inlet tube: fitted with a connector and protective cap. inlet tube has a protective cap, is non-kinking, has a length of +/-90cm and is fitted with a multi-sized connector. needle free sampling port must be present. bag or collector: fitted with a non-return valve. the non-return valve is located inside the urine collector bag at the upper part or urine entry point, and prevents urine backflow into the indwelling urinary catheter. non-return valve plus drainage valve allows maintenance of sterility inside the reservoir bag. urine bag has two (2) strong eyelets from which to suspend the bag. outlet tube: fitted with a drain valve. an outlet tube with a drain valve permits the bag to be emptied while limiting unnecessary handlings; thus, reducing infection risks. it is also more economical.unit presentation: 1 urine bag, single use, single packed in a peel or tear pouch. complies with en iso 8669-2: urine collection bags - part 2: requirements and test methods. or ce certified. additional requirements: bidder must provide clear brochure of the product. the pack shot showing all specified part is mandatory otherwise will not be considered for ts. only compliance letter will not be sufficient. ]
Tender For srphc82281210-coronary drug eluting stents (1) single wire technology on cobalt based alloy platform (2) stent with coating of biolinx polymer carrier for active drug zotarolimus shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter should be from 2.25 mm to 4 mm and length of the stent from 12mm to 38 mm. (4) the strut thickness should be 81 micron or less. (5) stent delivery system should be monorail (single operator exchange or rapid exchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved by dcgi. the copy of dcgi approval should be enclosed in the tender bid. (9) five years long term efficacy and safety of the stent in terms of target vesselrevascularisation (tvr) and in-situ thrombosis (ist) should be documented / published inpeer reviewed scientificjournals.(10) the documents pertaining to the efficacy and safety of the stent should be enclosed for the brand that is offered in the tender bid (11) the manufacturer/supplier should submit proof of supply of the stent to a major government institute.[quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]